| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Heart Lung Centre Utrecht, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, the Netherlands (RH, JMMvdB); Heart Lung Centre Utrecht, Department of Thoracic Surgery, University Medical Centre, Utrecht, the Netherlands (ABdlR); and St. Antonius Hospital, Department of Pathology, Nieuwegein, the Netherlands (CAS).
Correspondence: Address correspondence and reprint requests to: J. M. M. van den Bosch, MD, PhD, St. Antonius Hospital, Department of Pulmonology, PO Box 2500, 3435 EM Nieuwegein, the Netherlands; Fax: 31-30-605-2001; E-mail: j.vandenbosch{at}antonius.net
Pulmonary carcinoid tumors are neuroendocrine malignant tumors that make up 1% to 2% of all lung tumors. According to histopathologic criteria, carcinoids can be divided into typical (TC) and atypical (AC) carcinoids. Carcinoids can be placed in a spectrum of neuroendocrine tumors, ranging from low-grade malignant TC to intermediate AC to high-grade large-cell neuroendocrine carcinoma and small-cell lung carcinoma. Familial pulmonary carcinoids are rare. The most common symptoms are hemoptysis, cough, recurrent pulmonary infection, fever, chest discomfort and chest pain, unilateral wheezing, and shortness of breath. Paraneoplastic syndromes are rare and include carcinoid syndrome, Cushings syndrome, and ectopic growth hormonereleasing hormone secretion. The diagnosis is usually established by flexible bronchoscopy and biopsy, although occasionally this can result in severe hemorrhage. Immunoscintigraphy by somatostatin analogs can also be useful in diagnosis. The treatment of choice is surgical resection, and prognosis is relatively good in TC, although it is worse in AC. The role of radiotherapy and chemotherapy as part of multimodality treatment or palliation is still debated.
Key Words: Pulmonary carcinoid Pathology Classification Diagnosis Treatment
This article has been cited by other articles:
![]() |
W K de Jong, M Schaapveld, J L G Blaauwgeers, and H J M Groen Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours Thorax, December 1, 2008; 63(12): 1096 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bini, J. Brandolini, N. Cassanelli, F. Davoli, G. Dolci, F. Sellitri, and F. Stella Typical and atypical pulmonary carcinoids: our institutional experience Interactive CardioVascular and Thoracic Surgery, June 1, 2008; 7(3): 415 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Young, J. D. Mitchell, C. Cool, and S. P. Nana-Sinkam Wheezing and Exertional Dyspnea in a 25-Year-Old Mountaineer Chest, March 1, 2008; 133(3): 820 - 825. [Full Text] [PDF] |
||||
![]() |
S. Biswal, B. Srinivasan, P. Dutta, P. Ranjan, K. Vaiphei, R. S. Singh, and S. S. Thingnam Acromegaly Caused by Ectopic Growth Hormone: A Rare Manifestation of a Bronchial Carcinoid Ann. Thorac. Surg., January 1, 2008; 85(1): 330 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rugge, M. Fassan, R. Clemente, G. Rizzardi, L. Giacomelli, G. Pennelli, C. Mescoli, D. Segat, and F. Rea Bronchopulmonary Carcinoid: Phenotype and Long-term Outcome in a Single-Institution Series of Italian Patients Clin. Cancer Res., January 1, 2008; 14(1): 149 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A.P. Brokx, E. K. Risse, M. A. Paul, K. Grunberg, R. P. Golding, P. W.A. Kunst, J.-P. Eerenberg, J. C. van Mourik, P. E. Postmus, W. J. Mooi, et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Scarsbrook, A. Ganeshan, J. Statham, R. V. Thakker, A. Weaver, D. Talbot, P. Boardman, K. M. Bradley, F. V. Gleeson, and R. R. Phillips Anatomic and Functional Imaging of Metastatic Carcinoid Tumors RadioGraphics, March 1, 2007; 27(2): 455 - 477. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rea, G. Rizzardi, A. Zuin, G. Marulli, S. Nicotra, R. Bulf, M. Schiavon, and F. Sartori Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 186 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katabami, K. Okamoto, K. Ito, K. Kimura, and H. Kaji Bronchogenic glomangiomyoma with local intravenous infiltration. Eur. Respir. J., November 1, 2006; 28(5): 1060 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bertoletti, R. Elleuch, D. Kaczmarek, R. Jean-Francois, and J. M. Vergnon Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor. Chest, November 1, 2006; 130(5): 1405 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rea, G. Rizzardi, G. Marulli, and L. Bortolotti Metachronous bronchial carcinoid tumor. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 394 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Snabboon, W. Plengpanich, S. Siriwong, N. Wisedopas, S. Suwanwalaikorn, W. Khovidhunkit, and V. Shotelersuk A Novel Germline Mutation, 1793delG, of the MEN1 Gene Underlying Multiple Endocrine Neoplasia Type 1 Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 280 - 282. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kaltsas, G. M. Besser, and A. B. Grossman The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors Endocr. Rev., June 1, 2004; 25(3): 458 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cardillo, F. Sera, M. Di Martino, P. Graziano, R. Giunti, L. Carbone, F. Facciolo, and M. Martelli Bronchial carcinoid tumors: nodal status and long-term survival after resection Ann. Thorac. Surg., May 1, 2004; 77(5): 1781 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hage, A. B. de la Riviere, and J.M.M. van den Bosch Reply to Filosso Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 673 - 673. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |